Skip to content

13F-HR filed by Healthcare Value Capital, LLC

Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-08-14, with 30 holding rows worth $95,216,000.

Accession
0000919574-15-006071
Filed
2015-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2015

A holdings report, 30 entries on the cover page, a total value of $95,216,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $95,218,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALBANY MOLECULAR RESH012423109COMMON STOCK567,400$11,473,000thousands by filing date
QLT INC746927102COMMON STOCK2,107,200$8,703,000thousands by filing date
PROSHARES TR ULTSH NASD BIOT74347B789CEF300,000$8,616,000thousands by filing datecall
MANNKIND CORP56400P201COM1,470,000$8,364,000thousands by filing dateput
ANI PHARMACEUTICALS INC00182C103COM125,000$7,756,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR100,000$6,371,000thousands by filing date
Pfizer Inc.717081103COM150,000$5,030,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock66,208$4,801,000thousands by filing date
ARTIVION INC228903100COM370,000$4,174,000thousands by filing date
PROSHARES TR74348A319ULTSHT RUSS2000100,000$3,476,000thousands by filing date
PROSHARES TR74348A319ULTSHT RUSS2000100,000$3,476,000thousands by filing datecall
ALLERGAN PLCG0177J108SHS10,000$3,035,000thousands by filing date
PROSHARES TR ULTSH NASD BIOT74347B789CEF100,000$2,872,000thousands by filing date
Alliqua BioMedical Inc019621200COM NEW421,000$2,219,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW700,000$2,107,000thousands by filing datecall
AbbVie,Inc.00287Y109COM25,000$1,680,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM80,000$1,518,000thousands by filing date
PROSHARES TR II74347W361VIX STRMFUT ETF100,000$1,342,000thousands by filing datecall
APRICUS BIOSCIENCES INC03832V109COM650,000$1,112,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW400,000$984,000thousands by filing datecall
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK50,000$881,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM50,000$849,000thousands by filing datecall
FIBROCELL SCIENCE INC315721209COM NEW157,769$831,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM100,000$827,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW100,000$672,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW200,000$602,000thousands by filing date
ALIMERA SCIENCES INC016259103COM100,000$461,000thousands by filing date
ZOGENIX INC98978L105COM250,000$420,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM25,000$294,000thousands by filing date
XOMA CORP DEL98419J107COM70,000$272,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-15-006071this filing2015-08-14acceptance time not in the bulk data set